◆Research findings by Shinkuro Yamamoto, a graduate student in the Department of Urology at the School of Medicine, and Assistant Professor Hideo Fukuhara of the Division of Clinical Medicine in the School of Health Sciences have been published in the scientific journal *Photodiagnosis and Photodynamic Therapy*, which focuses on photodynamic therapy.
Release Date:
Research findings by Shinkuro Yamamoto, a graduate student in the Department of Urology at the School of Medicine, and Assistant Professor Hideo Fukuhara of the Division of Clinical Medicine in the School of Health Sciences have been published in the Dutch scientific journal *Photodiagnosis and Photodynamic Therapy* (the online version was released on September 10, 2020).
This study conducted a clinical evaluation of the requirement to perform photodynamic diagnosis within four hours of oral administration of 5-aminolevulinic acid (Araglio®)—a major constraint in the clinical practice of photodynamic diagnosis for bladder cancer to date.
In this study, Yamamoto and colleagues demonstrated that there is no difference in diagnostic accuracy or other clinical utility between taking Araglio® four hours or more after ingestion and taking it within four hours, and their findings were published in the journal.
These research findings may provide useful evidence for the implementation of photodynamic diagnosis for bladder cancer in future clinical practice.
Real-world experience with 5-aminolevulinic acid for the photodynamic diagnosis of bladder cancer: Diagnostic accuracy and safety
Japanese Translation: A study on the diagnostic accuracy and safety of photodynamic diagnosis using 5-aminolevulinic acid for bladder cancer in clinical practice
For details .